Incidental MRI Anomalies Suggestive of Multiple Sclerosis: The Radiologically Isolated Syndrome
Neurol 72:800-805,780, Okuda,D.T.,et al, 2009
Do Oligoclonal Bands Add Information to MRI in First Attacks of Multiple Sclerosis?
Neurol 70:1079-1083,1059, Tintore,M.,et al, 2008
Multiple Sclerosis
Lancet 372:1502-1517, Compston,A. &Coles,A., 2008
Specific Laboratory Test for Diagnosis of MS
BMJ 1:412, Field,E.J.,et al, 1974
The Optic Nerve Should Graduate to Be the Fifth Lesion Site for the Diagnosis of Multiple Sclerosis
Neurol 102:e207919, Galetta,S. & Brownlee, W., 2024
Management of Possible Multiple Sclerosis
NEJM 388:2195-2190, , 2023
Radiologically Isolated Syndrome: A Review for Neuroradiologists
AJNR 41:1542-1549, Hosseiny, M.,et al, 2020
Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis
JAMA Neurol 76:1446-1456, Sinnecker, T.,et al, 2019
Value of the Central Vein Sign at 3T to Differentiate MS from Seropositive NMOSD
Neurol 90:e1183-e1190, Cortese, R.,et al, 2018
Prodromal Symptoms of Multiple Sclerosis in Primary Care
Ann Neurol 83:1162-1173, Disanto,G.,et al, 2018
Application of the 2017 Revised McDonald Criteria for Multiple Sclerosis to Patients with a Typical Clinically Isolated Syndrome
JAMA Neurol 75:1392-1398, Van Der Vuurst De Vries, R.M.,et al, 2018
Misdiagnosis of Multiple Sclerosis
Neurol 92:15-16, Brownlee, W.J., 2018
Diagnosis of Multiple Sclerosis: Progress and Challenges
Lancet 389:1336-1346, Brownlee, W.J.,et al, 2017
Incidence of Radiologically Isolated Syndrome: A Population-Based Study
AJNR 37:1017-1022, Forslin, Y.,et al, 2016
Spinal Cord Lesions in Patients with Clinically Isolated Syndrome
Neurol 80:69-75, Sombekke, M.,et al, 2013
Prior Suggestive Symptoms in One-Third of Patients Consulting for a "First" Demyelinating Event
JNNP 82:323-325, Gout,O.,et al, 2011
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Ann Neurol 69:292-302, 234, Polman,C.H.,et al, 2011
MRI Criteria for MS in Patients with Clinically Isolated Syndromes
Neurol 74:427-434, Montalban,X.,et al, 2010
MRI in the Diagnosis of Pediatric Multiple Sclerosis
Neurol 72:961-967, Callen,D.J.A.,et al, 2009
A Single, Early Magnetic Resonance Imaging Study in the Diagnosis of Multiple Sclerosis
Arch Neurol 66:587-592, Rovira,A.,et al, 2009
Picturing Multiple Sclerosis: Conventional and Diffusion Tensor Imaging
Semin Neurol 28:453-466, Fox,R.J., 2008
What Went Wrong in the Natalizumab Trials?
Lancet 367:706-709, Langer-Gould,A.&Steinman,L., 2006
Diagnosis and Treatment of Multiple Sclerosis
BMJ 332:525-527, Murray,T.J., 2006
Accuracy of Magnetic Resonance Imaging for the Diagnosis of Multiple Sclerosis: Systematic Review
BMJ 332:875-878, Whiting P.,et al, 2006
Overdiagnosis of Multiple Sclerosis and Magnetic Resonance Imaging Criteria
Ann Neurol 58:781-783, Nielsen,J.M.,et al, 2005
Changes in the Ascertainment of Multiple Sclerosis
Neurol 65:1066-1070, Marrie,R.A.,et al, 2005
Diagnostic Criteria for Multiple Sclerosis: 2005 Revisions to the "McDonald Criteria"
Ann Neurol 58:840-846, Polman,C.H.,et al, 2005
Role of Magnetic Resonance Imaging Within Diagnostic Criteria for Multiple Sclerosis
Ann Neurol 56:273-278, Miller,D.H.,et al, 2004
New Diagnostic Criteria for Multiple Sclerosis
Neurol 60:27-30,6, Tintore,M.,et al, 2003
New T2 Lesions Enable an Earlier Diagnosis of Multiple Sclerosis in Clinically Isolated Syndromes
Ann Neurol 53:673-676, Dalton,C.M.,et al, 2003
Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis After a First Demyelinating Event
NEJM 349:139-145,107, Berger,T.,et al, 2003
The Utility of MRI in Suspected MS, Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 61:602-611,596, Frohman,E.M.,et al, 2003
Application of the New McDonald Criteria to Patients with Clinically Isolated Syndromes Suggestive of Mulitple Sclerosis
Ann Neurol 52:47-53, Dalton,C.M.,et al, 2002
Progressive Ventricular Enlargement in Patients with Clinically Isolated Syndromes is Associated with the Early Development of Multiple Sclerosis
JNNP 73:141-147, Dalton,C.M.,et al, 2002
Proton MR Spectroscopy of Tumefactive Demyelinating Lesions
AJNR 23:1378-1386, Saindane,A.M.,et al, 2002
Acute Disseminated Encephalomyelitis
Neurol 56:1313-1318,1257, Schwarz,S.,et al, 2001
Recommended Diagnostic Criteria for Multiple Sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
Ann Neurol 50:121-127, McDonald,W.I.,et al, 2001
Diagnostic Criteria for Primary Progressive Multiple Sclerosis: A Position Paper
Ann Neurol 47:831-835, Thompson,A.J.,et al, 2000
Practice Parameter: The Usefulness of Evoked Potentials in Identifying Clinically Silent Lesions in Patients With Suspected Multiple Sclerosis (an Evidence-Based Review)
Neurol 54:1720-1725, Gronseth,G.S.&Ashman,E.J., 2000
Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis
AJNR 21:702-706, Tintore,M.,et al, 2000
The Value of Diagnostic Information to Patients with Suspected Multiple Sclerosis
Arch Neurol 51:67-72, Mushlin,A.I.,et al, 1994
Effect of Diagnostic Testing for Multiple Sclerosis on Patient Health Perceptions
Arch Neurol 51:46-51, O'Connor,P.,et al, 1994
A Randomized Trial of Test Result Sequencing in Patients with Suspected Multiple Sclerosis
Arch Neurol 51:53-59, O'Connor,P.,et al, 1994
Cerebrospinal Fluid in the Diagnosis of Multiple Sclerosis:A consensus Report
JNNP 57:897-902, Andersson,M.,et al, 1994
The Accuracy of Magnetic Resonance Imaging in Patients with Suspected Multiple Sclerosis
JAMA 269:3146-3151, Mushlin,A.I.,et al, 1993
Assessment of MRI Criteria for a Diagnosis of MS
Neurol 43:905-909, Offenbacher,H.,et al, 1993
Multiple Sclerosis Masquerading as a Mass Lesion
Neuroradiolgoy 34:150-154, Giang,D.W.,et al, 1992
Magnetic Resonance Imaging and Laboratory Aids in the Diagnosis of Multiple Sclerosis
Ann Neurol 29:3-5, Paty,D.W.,et al, 1991
Proton MR Spectroscopy in Multiple Sclerosis:Value in Establishing Diagnosis, Monitoring Progression, and Evaluating Therapy
AJR 157:1073-1078, Richards,T.L., 1991